Abstract
Shengma-Gegen-Tang has long been used against measles virus in human peripheral blood mononuclear cells (PBMC) as well as in Vero cells. One hundred micrograms/ml Shengma-Gegen-Tang in PBMC displays significant anti-measles activity, whereas the same concentration in Vero cells does not. After eight days of infection, the release of virus is significantly suppressed by Shengma-Gegen-Tang in the case of PBMC. In addition, Shengma-Gegen-Tang has a selective stimulation to the secretion of cytokine TNF-alpha in PBMC. Time kinetic analysis indicated that the stimulation of secretion was rapid and could be detected only 2 hrs following the treatment of the PBMC. It rose to an optimal level in 8-12 hrs. These findings suggest that the magnification of anti-measles virus activity of this agent is lymphocyte dependent and may well be mediated by TNF-alpha.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antiviral Agents / pharmacology
-
Antiviral Agents / therapeutic use
-
Cell Division / drug effects
-
Cells, Cultured
-
Chlorocebus aethiops
-
Dose-Response Relationship, Drug
-
Drugs, Chinese Herbal / pharmacology*
-
Drugs, Chinese Herbal / therapeutic use
-
Enzyme-Linked Immunosorbent Assay
-
Humans
-
Interferon-gamma / metabolism
-
Kinetics
-
Leukocytes, Mononuclear / cytology
-
Leukocytes, Mononuclear / drug effects
-
Leukocytes, Mononuclear / virology*
-
Measles / drug therapy
-
Measles virus / drug effects*
-
Plant Extracts / pharmacology
-
Plant Extracts / therapeutic use
-
Plants, Medicinal / metabolism
-
Tumor Necrosis Factor-alpha / metabolism
-
Vero Cells / cytology
-
Vero Cells / drug effects
-
Vero Cells / virology*
-
Viral Plaque Assay
Substances
-
Antiviral Agents
-
Drugs, Chinese Herbal
-
Plant Extracts
-
Tumor Necrosis Factor-alpha
-
Interferon-gamma